Ritholtz Wealth Management’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,671
| Closed | -$12.1K | – | 704 |
|
|
2023
Q1 | $12.1K | Sell |
1,671
-1,389
| -45% | -$10.1K | ﹤0.01% | 638 |
|
|
2022
Q4 | $34.4K | Hold |
3,060
| – | – | ﹤0.01% | 571 |
|
|
2022
Q3 | $40K | Hold |
3,060
| – | – | ﹤0.01% | 707 |
|
|
2022
Q2 | $39K | Hold |
3,060
| – | – | ﹤0.01% | 537 |
|
|
2022
Q1 | $176K | Hold |
3,060
| – | – | 0.01% | 520 |
|
|
2021
Q4 | $363K | Hold |
3,060
| – | – | 0.02% | 371 |
|
|
2021
Q3 | $608K | Sell |
3,060
-3,926
| -56% | -$780K | 0.04% | 227 |
|
|
2021
Q2 | $1.22M | Hold |
6,986
| – | – | 0.09% | 113 |
|
|
2021
Q1 | $1.38M | Hold |
6,986
| – | – | 0.12% | 84 |
|
|
2020
Q4 | $1.37M | Hold |
6,986
| – | – | 0.13% | 69 |
|
|
2020
Q3 | $1.24M | Hold |
6,986
| – | – | 0.14% | 68 |
|
|
2020
Q2 | $1.62M | Sell |
6,986
-2,000
| -22% | -$462K | 0.21% | 45 |
|
|
2020
Q1 | $1.05M | Sell |
8,986
-800
| -8% | -$93.2K | 0.17% | 49 |
|
|
2019
Q4 | $1.87M | Sell |
9,786
-800
| -8% | -$153K | 0.27% | 35 |
|
|
2019
Q3 | $2.04M | Sell |
10,586
-1,035
| -9% | -$199K | 0.33% | 30 |
|
|
2019
Q2 | $1.99M | Hold |
11,621
| – | – | 0.34% | 30 |
|
|
2019
Q1 | $2.34M | Hold |
11,621
| – | – | 0.43% | 26 |
|
|
2018
Q4 | $2.18M | Buy |
+11,621
| New | +$2.18M | 0.49% | 28 |
|